IP Verse

Culture Method For Obtaining A Clonal Population Of Antigen-Specific B Cells

Patent No. EP2021463 (titled "Culture Method For Obtaining A Clonal Population Of Antigen-Specific B Cells") was filed by Alder Biopharmaceuticals on May 21, 2007. The application was issued on Nov 23, 2016.

Patent Summary

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
UCB BIOPHARMA SPRL	Aug 23, 2017	J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Jul 17, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Jul 17, 2018
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Jul 10, 2018
Termination of the opposition proceedings with revocation of patent
Jul 3, 2018
Submission concerning representation
May 28, 2018
Brief communication - Opposition proceedings
May 28, 2018
Brief communication - Opposition proceedings
May 11, 2018
(Electronic) Receipt
May 11, 2018
Letter accompanying subsequently filed items
May 11, 2018
Request for revocation of patent
May 8, 2018
Advice of delivery
May 1, 2018
(Electronic) Receipt
May 1, 2018
Advice of delivery
May 1, 2018
Letter accompanying subsequently filed items
Apr 26, 2018
Acknowledgement of a document
Apr 26, 2018
Acknowledgement of a document
Apr 26, 2018
Decision of the Opposition Division and instruction
Apr 26, 2018
Decision revoking the European patent
Apr 26, 2018
Internal form - Opposition/addressees
Oct 9, 2017
Brief communication - Opposition proceedings
Oct 3, 2017
(Electronic) Receipt
Oct 3, 2017
Any annexes (other than citation) to an opposition letter
Oct 3, 2017
Letter accompanying subsequently filed items
Oct 3, 2017
Letter regarding the opposition procedure (no time limit)
Sep 27, 2017
Communication of a notice of opposition and request to file observations
Sep 27, 2017
Notice of further oppositions to opponent(s)
Sep 1, 2017
Communication of a notice of opposition - first information to patent proprietor
Aug 23, 2017
(Electronic) Receipt
Aug 23, 2017
Any annexes (other than citation) to an opposition letter
Aug 23, 2017
Non-patent literature cited during the opposition procedure
Aug 23, 2017
Non-patent literature cited during the opposition procedure
Aug 23, 2017
Non-patent literature cited during the opposition procedure
Aug 23, 2017
Non-patent literature cited during the opposition procedure
Aug 23, 2017
Non-patent literature cited during the opposition procedure
Aug 23, 2017
Notice of opposition
Aug 23, 2017
Notice of opposition
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Aug 23, 2017
Patent document cited during the opposition procedure
Nov 23, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Oct 27, 2016
Decision to grant a European patent
Oct 11, 2016
(Electronic) Receipt
Oct 11, 2016
Filing of the translations of the claims
Oct 11, 2016
French translation of claims
Oct 11, 2016
German translation of the claims
Oct 11, 2016
Letter accompanying subsequently filed items
Jun 10, 2016
Bibliographic data of the European patent application
Jun 10, 2016
Communication about intention to grant a European patent
Jun 10, 2016
Intention to grant (signatures)
Jun 10, 2016
Text intended for grant (clean copy)
Jun 10, 2016
Text intended for grant (version for approval)
Sep 14, 2015
(Electronic) Receipt
Sep 14, 2015
Amended claims with annotations
Sep 14, 2015
Amended description with annotations
Sep 14, 2015
Claims
Sep 14, 2015
Description
Sep 14, 2015
Letter accompanying subsequently filed items
Sep 14, 2015
Reply to communication from the Examining Division
Jul 6, 2015
Grant of extension of time limit (examination procedure)
Jun 30, 2015
(Electronic) Receipt
Jun 30, 2015
Letter accompanying subsequently filed items
Jun 30, 2015
Request for extension of time limit to communication from the Examining Division
Mar 3, 2015
Annex to the communication
Mar 3, 2015
Communication from the Examining Division
Mar 10, 2014
(Electronic) Receipt
Mar 10, 2014
Amended claims with annotations
Mar 10, 2014
Claims
Mar 10, 2014
Letter accompanying subsequently filed items
Mar 10, 2014
Reply to communication from the Examining Division
Dec 5, 2013
Communication of amended entries concerning the representative
Nov 8, 2013
Submission concerning change of applicant's representative
Nov 6, 2013
Submission concerning change of applicant's representative
Oct 30, 2013
Annex to the communication
Oct 30, 2013
Communication from the Examining Division
Mar 9, 2012
Decision to allow further processing
Feb 22, 2012
(Electronic) Receipt
Feb 22, 2012
Claims
Feb 22, 2012
Letter accompanying subsequently filed items
Feb 22, 2012
Request for further processing
Dec 14, 2011
Application deemed to be withdrawn (no reply to communication from the Examining Division)
Sep 5, 2011
Request for extension of time limit to communication from the Examining Division
Sep 1, 2011
Grant of extension of time limit (examination procedure)
Aug 26, 2011
Request for extension of time limit to communication from the Examining Division
Apr 29, 2011
Annex to the communication
Apr 29, 2011
Communication from the Examining Division
Apr 13, 2010
Claims
Apr 13, 2010
Reply to communication from the Examining Division
Apr 12, 2010
Claims
Apr 12, 2010
Reply to communication from the Examining Division
Jan 20, 2010
Grant of extension of time limit (examination procedure)
Jan 15, 2010
Request for extension of time limit to communication from the Examining Division
Jan 13, 2010
Request for extension of time limit to communication from the Examining Division
Oct 7, 2009
Communication from the Examining Division
Sep 2, 2009
Maintenance of the application
Sep 1, 2009
Maintenance of the application
Aug 18, 2009
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jul 31, 2009
Communication regarding the transmission of the European search report
Jul 31, 2009
European search opinion
Jul 31, 2009
Supplementary European search report
May 18, 2009
Non-scannable object
May 18, 2009
Reply to the invitation to remedy deficiencies
May 18, 2009
Sequence listing
May 15, 2009
Payment of fees and costs
May 15, 2009
Reply to the invitation to remedy deficiencies
May 15, 2009
Sequence listing
Mar 31, 2009
Deficiencies in sequence listing
Jan 14, 2009
Notification on forthcoming publication of bibliographic data
Jan 7, 2009
Communication regarding possible amendment of claims/payment of claims fees
Dec 9, 2008
Copy of the international preliminary report on patentability
Nov 21, 2008
Amended claims filed after receipt of (European) search report
Nov 21, 2008
Amended claims filed after receipt of (European) search report
Nov 21, 2008
Matter concerning the application
Nov 21, 2008
Request for entry into the European phase
Apr 17, 2008
Copy of the international search report
Apr 17, 2008
Priority document (electronically transmitted)
Apr 17, 2008
Published international application - A1

EP2021463

ALDER BIOPHARMACEUTICALS

Application Number: EP07861311A
Filing Date: May 21, 2007
Status: Revoked; Jul 13, 2018
Publication Date: Nov 23, 2016
External Links: Slate, Register , Google Patents